What smart money is saying about Cellebrite DI Ltd.
7 funds in our archive have pitched Cellebrite DI Ltd. — most recently Voss Capital in December 2025.
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.
Fund coverage · 7 theses
- Voss CapitalDecember 2025
Cellebrite is a hardware-enabled digital forensics platform with a deep exploit library, high legal and procurement barriers, emerging AI products, and strong growth and cash generation at a discounted valuation.
Read the full thesis - Artisan U.S. Small-Cap Growth StrategyDecember 2025
Cellebrite DI Ltd provides digital forensics software and is transitioning to an integrated platform with durable franchise advantages and expected growth resumption.
Read the full thesis - Greenhaven Road CapitalSeptember 2025
Cellebrite is well-positioned for future growth due to its unique products, high customer value, and upcoming AI tools, despite current market challenges.
Read the full thesis - Voss CapitalSeptember 2025
Cellebrite (CLBT) is a high-margin, cash-generating software platform transforming federal law enforcement through accelerating growth drivers and strategic acquisitions, trading at depressed valuations that imply over 90% upside as the market re-rates its long-term potential.
Read the full thesis - Voss CapitalJune 2025
Cellebrite is well-positioned for renewed growth, demonstrating strong gross margins and free cash flow, despite a minor revenue guidance cut, as they reset expectations and manage federal contract timing effectively.
Read the full thesis - Polen Global SMID Company GrowthDecember 2024
Cellebrite is a leading Israeli company in digital forensics software, experiencing strong demand for its services to help law enforcement and poised for significant revenue growth while trading at a discount compared to global peers.
Read the full thesis - Greenhaven Road CapitalDecember 2024
Cellebrite is a rapidly growing and profitable company with a strong recurring revenue growth, an upgrade cycle on the horizon, and potential benefits from AI integration, while facing uncertainty regarding its leadership and future independence.
Read the full thesis
Read every full thesis on Cellebrite DI Ltd.
Unlock all 7 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→